Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -155404.38% is 881% below its 1-year average of -15838.12%, near the low end of its 1-year range (-155404.38%–0.00%).
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-155404.38%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-59770815.38%
vs the sector median at left
Neonc Technologies Holdings, Inc.
Market Cap
$77.54M
Net Profit Margin
-155404.38%
TTM Avg
0.00%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$78.07M
Net Profit Margin
-130000.00%
TTM Avg
-89627.13%
3Y Avg
-49555.20%
5Y Avg
-36262.68%
Market Cap
$78.29M
Net Profit Margin
-47475.71%
TTM Avg
-41070.98%
3Y Avg
-27618.26%
5Y Avg
-38759.83%
Market Cap
$76.74M
Net Profit Margin
-63.06%
TTM Avg
-90.45%
3Y Avg
-113.67%
5Y Avg
-137.76%
Market Cap
$78.59M
Net Profit Margin
-12.91%
TTM Avg
-907.67%
3Y Avg
-691.25%
5Y Avg
-536.96%
Market Cap
$79.03M
Net Profit Margin
-648.32%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$75.95M
Net Profit Margin
-9.79%
TTM Avg
-5.93%
3Y Avg
-6.23%
5Y Avg
-32.51%
Market Cap
$79.61M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$75.18M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neonc Technologies Holdings, Inc. (NTHI) | $77.54M | -155404.38% | 0.00% | N/A | N/A |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -130000.00% | -89627.13% | -49555.20% | -36262.68% |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | -47475.71% | -41070.98% | -27618.26% | -38759.83% |
| Outset Medical, Inc. (OM)vs › | $76.74M | -63.06% | -90.45% | -113.67% | -137.76% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | -12.91% | -907.67% | -691.25% | -536.96% |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | -648.32% | 0.00% | 0.00% | 0.00% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.95M | -9.79% | -5.93% | -6.23% | -32.51% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulmonx Corporation (LUNG)vs › | $75.18M | -55.03% | -63.48% | -81.34% | -87.39% |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -4560.82% | -1001.79% | -692.03% | -1554.36% |
Operating Margin
-145459.4%
Net Profit Margin
-155404.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -95028.72% |
